a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders
Industry Biotechnology
A.I.dvisor indicates that over the last year, PHAT has been loosely correlated with TCRX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PHAT jumps, then TCRX could also see price increases.
Ticker / NAME | Correlation To PHAT | 1D Price Change % | ||
---|---|---|---|---|
PHAT | 100% | +2.83% | ||
TCRX - PHAT | 33% Loosely correlated | -1.33% | ||
ABP - PHAT | 32% Poorly correlated | -3.91% | ||
ALDX - PHAT | 32% Poorly correlated | +5.34% | ||
ABOS - PHAT | 30% Poorly correlated | -0.51% | ||
ROIV - PHAT | 30% Poorly correlated | +0.41% | ||
More |